Printer Friendly
The Free Dictionary
990,234,946 visitors served.
?
Dictionary/
thesaurus
Medical
dictionary
Legal
dictionary
Financial
dictionary
Acronyms
 
Idioms
Encyclopedia
Wikipedia
encyclopedia
?

transplant
(redirected from Transplant rejection)

   Also found in: Dictionary/thesaurus, Medical, Wikipedia, Hutchinson 0.01 sec.

transplant

 or graft

Partial or complete organ or other body part removed from one site and attached at another. It may come from the same or a different person or an animal. One from the same person—most often a skin graft—is not rejected. Transplants from another person or, especially, an animal are rejected unless they are unusually compatible or have no blood vessels (e.g., the cornea), or if the recipient's immune reaction is suppressed by lifelong drug treatment. Transplanted tissues must match (by blood tests) more closely than blood transfusions. Monoclonal antibodies targeting the cells that cause rejection hold great promise. Tests are now under way with monoclonal antibodies that react with antigens present only on T cells that are participating in rejection, sparing the rest. Rejection matters less in skin grafts, which may need to last only weeks, and bone grafts, whose structure remains after the cells die. In bone-marrow transplants, the donor's marrow cells may attack the recipient's tissues, often fatally. Lung transplants have greater chance of success as part of a heart-and-lung transplant. See also heart transplant, kidney transplant.


?Page tools
Printer friendly
Cite / link
Email
Feedback
? Mentioned in ? References in periodicals archive
 
Tokyo, Japan, Apr 24, 2006 - (JCN) - Astellas Pharma recently announced the European Commission's approval of the Company's proprietary immunosuppressant Prograf (tacrolimus) for the prophylaxis use of transplant rejection in heart transplant recipients in all EU countries.
Of the people waiting for a kidney transplant, about one third have a less common tissue type which produces antibodies leading to transplant rejection.
The drug, which is currently undergoing clinical trials in the United States and Europe, is intended for the noninvasive diagnosis of cardiac transplant rejection.
 
Encyclopedia browser? ? Full browser
 
 
Encyclopedia
?

Disclaimer | Privacy policy | Feedback | Copyright © 2008 Farlex, Inc.
All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional. Terms of Use.